Key Details

  • Symbol (NSE): EXPLEOSOL
  • Sender: S. Sampath Kumar, Company Secretary & Compliance Officer (M. No. FCS 3838)

Event Details

  • A meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 27, 2026.
  • The agenda for the meeting includes, inter-alia, to consider Dividend, if any, for the Financial Year 2025-26.